Stock screener

LGND

Conviction 66HealthcareScan · Tue, Sep 8, 2026
Bullish engulfing
LGND$288.87+1.14%
ResistanceSupportVol 14Insider sellCongress buyCongress sell
63 bars
2
Vol MA14 171.67K
Jun 9Jun 26Jul 16Aug 3Aug 20Sep 8
LIGAND PHARMACEUTICALS INCPHARMACEUTICAL PREPARATIONSwww.ligand.com ↗
Price288.87
Change+1.14%
Gap-0.21%
Rel volume0.70×
Avg volume199.88K
Avg $ vol57.51M
SMA 20287.17
SMA 50297.23
SMA 200232.80
Price vs 50-2.81%
Price vs 200+24.08%
MA stackmixed
50/200 cross—
Supertrenddown · 308.72
RSI (14)50
MACD hist0.42
MACD crossbull · 2d
Stoch %K / %D70 / 62
ADX (14)12
+DI / −DI12 / 19
RSI divergence—
MACD divergence—
ATR %+3.22%
ADR %2.95%
52w high322.61
52w low165.41
From 52w high-10.46%
Above 52w low+74.64%
New 52w highNo
SqueezeOn · 23d
Bollinger width5.33%
%B0.61
Donchian pos55.88%
Donchian high299.34
Donchian low275.60
AVWAP (52w high)297.19
vs AVWAP high-2.80%
AVWAP (52w low)233.43
vs AVWAP low+23.75%
OBV trendFlat
Chaikin MF (20)-0.06
Today vs 20d0.70×
Avg vol (14d)171.67K
Avg vol (20d)199.88K
Avg $ vol (20d)57.51M
Market cap5.76B
RS 3m (vs SPY)+16.08%
RS 6m (vs SPY)+26.91%
RS line new highNo
Trend template7/8
Technical rank67.7
1 week+1.68%
1 month-1.46%
3 months+21.50%
6 months+38.77%
1 year+73.23%
YTD+51.95%
P/E46.27
P/B5.95
P/S21.48
P/FCF117.75
EPS6.13
Div yield—
ROE12.86%
ROA5.69%
Debt/Eq1.16
Current31.18
EV/EBITDA78.61
Gross margin—
Net margin46.42%
Rev growth60.40%
EPS growth3186.63%
Price target350.86
Target upside21.46%
Analyst ratingBuy
Institutional129.05%
Ent. value5.88B
Revenue63.69M
Net income48.51M
Gross profit—
Free cash flow48.91M
IndustryPHARMACEUTICAL PREPARATIONS
ExchangeNasdaq
Shares out20.04M
Employees47
ListedFri, Nov 25, 1994
Free float18.87M
Float %95.9%
Short interest2.45M
Days to cover8.8d
Short volume72.7%
Squeeze score71 / 100
Next earnings—
EPS forecast—
Last EPS vs est$2.22 vs $1.34
Last surprise+65.7% beat
Setup gradeB
Conviction66 / 100
Pattern quality—
Tech rank67.7 / 100
Group rank96 / 100 · Leading
Status lane—
Setup direction—
Pattern family
Resistance—
Support—
Days since event—
Candle confirmBullish engulfing
News sentiment—

Financials as of Tue, Jun 30, 2026 · quarterly.

Congress activity

Disclosed STOCK Act trades in LGND · 2 recent

All disclosures →
MemberSideAmount
Gilbert Cisneros
Gilbert Cisneros
house · CA · traded 2026-05-29
Buy$1K–$15K
Gilbert Cisneros
Gilbert Cisneros
house · CA · traded 2026-01-15
Buy$1K–$15K

Insider activity

SEC Form 4 transactions in LGND · 5 buys · 5 sells

InsiderSideShares
Espinoza Octavio
Chief Financial Officer · Common Stock · 2026-08-12
Exercise16.18K
Espinoza Octavio
Chief Financial Officer · Common Stock · 2026-08-12
Exercise2.07K
Espinoza Octavio
Chief Financial Officer · Common Stock · 2026-08-12
Exercise2.87K
Espinoza Octavio
Chief Financial Officer · Common Stock · 2026-08-12
Exercise7.17K
Espinoza Octavio
Chief Financial Officer · Common Stock · 2026-08-12
Exercise3.35K
Espinoza Octavio
Chief Financial Officer · Common Stock · 2026-08-12
Sell31.64K
Espinoza Octavio
Chief Financial Officer · Employee Stock Option (right to buy) · 2026-08-12
Exercise2.87K
Espinoza Octavio
Chief Financial Officer · Employee Stock Option (right to buy) · 2026-08-12
Exercise7.17K
Espinoza Octavio
Chief Financial Officer · Non-Qualified Stock Option (right to buy) · 2026-08-12
Exercise16.18K
Espinoza Octavio
Chief Financial Officer · Non-Qualified Stock Option (right to buy) · 2026-08-12
Exercise3.35K

SEC filings

EDGAR filings in LGND · 10 recent

EDGAR →

Get daily signals & real-time alerts.

StockSetups scans ~12,300 US stocks & ETFs after every close and sorts every long setup into four ranked lanes — each with a trade plan — plus an always-on engine firing 35+ real-time intraday alerts. Free for 14 days, cancel in one click.

Start free — 14-day full access →

Educational data, not financial advice. Patterns, levels and the trade plan are algorithmic, not a recommendation to trade.